Page 60 - CSIR-IGIB Annual Report 2020-21
P. 60

related  macular degeneration (wAMD) and          currently available CRISPR-Cas gene editing.
                Leber congenital amaurosis (LCA) are two such     VEGF A and  RPE65 gene  for wAMD and LCA
                retinal diseases due to mutations in VEGFA and    disease are being targeted, respectively.
                RPE65  genes respectively. The current use of     Therefore, sgRNA were designed with respect to
                gene editing technologies like CRISPR-Cas are     the target gene using available software. In vitro
                limited by the delivery of the enzyme complexes   transcription based sgRNA synthesis was
                into the  target  cells besides off targeting and   preferred,  thus forward primer and  universal
                DSBs. This project utilizes lipopolymeric         reverse primer were designed to target the
                nanoplexes  of CRISPR/Cas9 ribonucleoprotein      VEGFA  and  RPE65.  Herein, more than two
                (RNP) complex to correct these disease-causing    sgRNA were  designed for one target  gene in
                mutations. FnCas9 which has a high mismatch       order to evaluate the specificity. Both, eGFP
                sensitivity and  specificity  with  very  less off-  tagged as well as normal Cas9 protein were
                target effects is being deployed in this approach   purified and characterized for its endonuclease
                to overcome the other two limitations of          activity.

                Publications
                Role of lncRNAs in stem cell maintenance and differentiation. Aich M, Chakraborty D. Curr  Top Dev Biol.
                2020;138:73-112.

                Terminal  uridylyl transferase mediated site-directed access to  clickable chromatin employing  CRISPR-dCas9.
                George JT, Azhar M, Aich M, Sinha D, Ambi UB, Maiti S, Chakraborty D, Srivatsan SG. J Am Chem Soc. 2020 Aug
                12;142(32):13954-13965.

                Ophthalmic genetics practice and research in India: Vision in 2020. Bansal M, Tandon R, Saxena R, Sharma A, Sen
                S, Kishore A, Venkatesh P, Maiti S, Chakraborty D. Am J Med Genet C Semin Med Genet. 2020 Sep;184(3):718-727.

                Voices of biotech research. Annabi N, Baker M, Boettiger A, Chakraborty D, Chen Y, Corbett KS, Correia B, Dahlman
                J, de  Oliveira T, Ertuerk A,  Yanik MF, Henaff  E, Huch  M, Iliev ID, Jacobs T, Junca  H,  Keung A,  Kolodkin-Gal I,
                Krishnaswamy S, Lancaster M, Macosko E, Martínez-Núñez MA, Miura K, Molloy J, Cruz AO, Platt RJ, Posey AD Jr,
                Shao  H,  Simunovic M,  Slavov N, Takebe T, Vandenberghe LH,  Varshney RK,  Wang J. Nat Biotechnol. 2021
                Mar;39(3):281-286.

                Preprint
                Rapid, accurate, nucleobase detection using FnCas9 Mohd. Azhar, Rhythm Phutela, Manoj Kumar, Asgar Hussain
                Ansari, Riya Rauthan, Sneha Gulati, Namrata Sharma, Dipanjali Sinha, Saumya Sharma, Sunaina Singh, Sundaram
                Acharya, Deepanjan Paul, Poorti Kathpalia, Meghali Aich, Paras Sehgal, Gyan Ranjan, Rahul C. Bhoyar, Indian CoV2
                Genomics & Genetic Epidemiology (IndiCovGEN) Consortium, Khushboo Singhal, Harsha Lad, Pradeep Kumar Patra,
                Govind Makharia, Giriraj Ratan Chandak, Bala Pesala, Debojyoti Chakraborty, Souvik Maiti medRxiv
                2020.09.13.20193581





















               Annual Report 2020-21                                                                       57
   55   56   57   58   59   60   61   62   63   64   65